Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's ...

The Quadruple Aim—a framework originally rooted in improving patient experience, enhancing population health, and achieving ...

A new drug application (NDA) has been submitted to the FDA for sunvozertinib in pretreated EGFR exon 20–positive advanced non ...

A total of 7 states passed ballot measures during the 2024 presidential election to enshrine abortion access into their state ...

The study evaluated a reduced-intensity conditioning regimen without total body irradiation for alloHCT in DC/TBD patients.

The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting ...

RILD in NHL patients presents as lung disease, organizing pneumonia, and nonspecific interstitial pneumonia, with 179 ...

Inteleclinic AI tool automates neuromuscular exam scoring, reducing time and ensuring consistent assessments across settings.

Amit Saxena, MD, discusses how personalized treatment decisions for lupus nephritis require careful consideration of patient characteristics, multidisciplinary coordination, and emerging guidelines, ...

Amit Saxena, MD, discusses how evidence-based guidelines from ACR and KDIGO have evolved to shape lupus nephritis treatment approaches, emphasizing their critical role in standardizing patient care ...

Timely intervention in oncology is critical for improving survival rates, disease progression, and quality of life. Delays in treatment can result in advanced disease stages, reduced treatment ...

Poor sleep quality in PAH patients is linked to increased dyspnea and reduced exercise capacity, worsening disease burden. Severe dyspnea is a significant predictor of poor sleep quality, independent ...